Merck Healthcare Kgaa, Darmstadt, Germany, An Affiliate Of Merck Kgaa, Darmstadt, Germany

This early-phase study tests an experimental drug called M9140 in 12 Chinese adults with advanced colorectal cancer that has not responded to standard treatments. The drug is designed to deliver chemotherapy directly to cancer cells that carry a specific marker (CEACAM5). The mai…

This study looks at the long-term safety of enpatoran, an oral medication, in people with lupus who have already finished a 24-week treatment in a previous study. About 379 participants will take different doses of the drug and be monitored for side effects. The goal is to see if…

This study follows 367 adults with relapsing multiple sclerosis to find out which patient traits predict how well cladribine tablets work and how safe they are in everyday practice. Researchers will track how long people stay on the drug, relapses, and other outcomes over time. T…

This study looks back at medical records of 360 Japanese patients with advanced bladder cancer who received avelumab as a maintenance therapy after initial chemotherapy. The goal is to understand patient characteristics, treatment patterns, and outcomes like survival and tumor re…